DORIA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.886
EU - Europa 3.879
AS - Asia 2.501
Continente sconosciuto - Info sul continente non disponibili 24
SA - Sud America 23
AF - Africa 22
OC - Oceania 20
Totale 36.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.846
CN - Cina 1.552
IT - Italia 1.359
FI - Finlandia 695
SG - Singapore 617
DE - Germania 536
SE - Svezia 378
UA - Ucraina 317
GB - Regno Unito 301
VN - Vietnam 165
IN - India 90
NL - Olanda 63
IE - Irlanda 62
FR - Francia 53
CA - Canada 34
EU - Europa 22
ES - Italia 21
RU - Federazione Russa 17
JP - Giappone 15
TR - Turchia 15
HK - Hong Kong 14
AU - Australia 13
BR - Brasile 12
PL - Polonia 12
CH - Svizzera 11
EG - Egitto 8
RO - Romania 8
CZ - Repubblica Ceca 7
NZ - Nuova Zelanda 7
PE - Perù 7
ZA - Sudafrica 7
LU - Lussemburgo 6
PK - Pakistan 6
GR - Grecia 5
RS - Serbia 5
BE - Belgio 4
IR - Iran 4
MX - Messico 4
BD - Bangladesh 3
BY - Bielorussia 3
ID - Indonesia 3
KR - Corea 3
MY - Malesia 3
NO - Norvegia 3
SA - Arabia Saudita 3
SM - San Marino 3
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
MA - Marocco 2
MK - Macedonia 2
SI - Slovenia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
ZM - Zambia 1
Totale 36.355
Salva come PNG Salva come JPEG
Città #
Fairfield 5.429
Woodbridge 3.039
Houston 2.504
Chandler 2.291
Ashburn 2.202
Cambridge 1.901
Seattle 1.891
Ann Arbor 1.889
Wilmington 1.765
Jacksonville 1.565
Princeton 817
San Diego 555
Medford 392
Singapore 377
Des Moines 366
Beijing 364
Nanjing 307
Helsinki 265
Padova 261
Roxbury 200
Boardman 171
Dong Ket 163
New York 98
Hebei 94
Shenyang 91
Milan 90
Nanchang 78
Rome 77
Guangzhou 76
Redwood City 68
London 67
Jinan 65
Dearborn 64
Norwalk 62
Jiaxing 58
Changsha 56
Ogden 47
Dublin 44
Tianjin 39
Lappeenranta 28
Kilburn 27
Falls Church 26
Hefei 26
Kharkiv 26
Shanghai 25
Los Angeles 23
Kunming 22
Bari 21
Bologna 21
Florence 21
Amsterdam 20
Verona 19
Washington 18
Zhengzhou 17
Borås 16
Genoa 16
Venice 16
Rockville 15
Trois-Rivières 15
Arezzo 14
Las Vegas 14
Nürnberg 14
Chicago 13
Haikou 13
Munich 13
Ningbo 13
Naples 12
Paris 12
Turin 12
Madrid 11
Acton 10
Ferrara 10
Indiana 10
Udine 10
Düsseldorf 9
Hangzhou 9
Islington 9
Pasian di Prato 9
Prescot 9
Treviso 9
Vicenza 9
Miami 8
Phoenix 8
São Paulo 8
Tappahannock 8
Trieste 8
Tübingen 8
Wandsworth 8
Gdansk 7
Hounslow 7
Lanzhou 7
Lima 7
Lucca 7
Palermo 7
Pune 7
Redmond 7
Taizhou 7
Ankara 6
Fuzhou 6
New Bedfont 6
Totale 30.687
Salva come PNG Salva come JPEG
Nome #
Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: studio sierologico di 46 pazienti. 198
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 179
Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. 172
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): A new SLE continuous measure with high sensitivity for changes in disease activity 160
Pregnancy and vasculitis: A systematic review of the literature. 158
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 157
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 156
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 150
Advances in the Diagnosis and Classification of Systemic Lupus Erythematosus 147
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 143
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 142
Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at clinical onset of disease: evidence from skeletal muscle biopsies. 140
Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age? 139
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission 137
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 134
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. 134
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 133
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 131
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 130
Antigen preparation for immunological studies in systemic autoimmune diseases. 129
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. 127
The kaleidoscope of glucocorticoid effects on immune system 126
Autoinflammation and autoimmunity: Bridging the divide. 126
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression 123
Antigen preparation for immunological studies in systemic autoimmune diseases 123
OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. 122
Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus 122
Infections and autoimmunity: the multifaceted relationship. 121
Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity 119
IL-12 and IL-23/Th17 axis in systemic lupus erythematosus 119
SERPINB3, apoptosis and autoimmunity 118
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. 118
A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab--comments on article by Fredericks et al. 117
Overlap connective tissue disease syndromes. 116
The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients 116
Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review 115
Therapy of scleroderma renal crisis: State of the art 113
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs 112
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 112
Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: A literature review 112
Success and failure of biological treatment in systemic lupus erythematosus: A critical analysis 112
Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α 112
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 112
Polymyositis, dermatomyositis and malignancy: A further intriguing link. 110
The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. 110
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. 110
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 110
Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease 109
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 109
Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus 108
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases. 108
Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. 107
Medium-/long-term effects of a specific exercise protocol combined with patient education on spine mobility, chronic fatigue, pain, aerobic fitness and level of disability in fibromyalgia. 106
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups 106
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 106
LIPOPROTEIN COMPOSITIONAL ABNORMALITIES IN TYPE 1 (INSULIN-DEPENDENT) DIABETIC PATIENTS 103
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 103
Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis. 103
Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? 103
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes 103
PRESENCE, GRADE AND LOCATION OF POWER DOPPLER PREDICT PROGRESSION OF RADIOGRAPHIC DAMAGE IN TNFα BLOCKER INDUCED CLINICAL REMISSION IN RHEUMATOID ARTHRITIS PATIENTS 103
The clinical features, diagnosis and classification of dermatomyositis. 103
Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association 103
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 103
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 103
A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome 102
Self-reported flares are predictors of radiographic progression in rheumatoid arthritis patients in 28-joint disease activity score remission: a 24-month observational study 101
Breast prostheses and connective tissue disease (CTD): myth or reality? 100
Primary prevention of systemic lupus erythematosus. 100
Adalimumab in psoriatic arthritis 99
null 99
Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies 99
Cell stress-response in skeletal muscle myofibers 98
Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity-a Comprehensive Review. 98
Clinical implications of autoantibody screening in patients with autoimmune myositis. 98
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients 98
New therapeutic strategies in systemic lupus erythematosus management 98
The periprosthetic capsule and connective tissue diseases: a piece in the puzzle of autoimmune / autoinflammatory syndrome induced by adjuvants. 97
Prognosis of scleroderma renal crisis: a long-term observational study. 97
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 97
Polymyositis-dermatomyositis and infections. 96
Commercial blot assays in the diagnosis of systemic rheumatic diseases 96
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. 96
Myositis autoantibodies and clinical phenotypes 96
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses 96
Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus 96
Seltene autoimmune rheumatische erkrankungen in der schwangerschaft: systemische sklerose, dermato-polymyositis und vaskulitiden. 95
Cutting Edge Issues in Polymyositis 95
Predictors of maternal and fetal complications in SLE patients: a prospective study. 95
Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus 95
SLE diagnosis and treatment: When early is early 95
Can we manage lupus nephritis without chronic corticosteroids administration? 95
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 95
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment 94
2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus 94
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 94
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? 93
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 93
Anti-double-stranded DNA antibodies in the healthy elderly: prevalence andcharacteristics 93
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 93
Totale 11.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.995
article - articoli 132.789
book - libri 504
conference - conferenze 0
curatela - curatele 0
other - altro 102
patent - brevetti 0
selected - selezionate 0
volume - volumi 869
Totale 272.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.768 0 268 90 758 812 628 780 891 830 812 466 433
2020/20216.596 244 522 218 487 212 488 195 566 931 653 673 1.407
2021/20226.764 171 711 752 549 281 497 260 758 334 263 630 1.558
2022/20234.900 1.199 463 98 514 747 599 32 347 545 62 221 73
2023/20243.210 116 348 316 248 218 311 218 137 253 159 409 477
2024/2025123 109 14 0 0 0 0 0 0 0 0 0 0
Totale 36.895